Classification of tau status with machine learning models in amyloid‐positive cohorts
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Yun-Chi Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, School of Engineering, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Machine Learning, tau Proteins, Alzheimer Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NCATS NIH HHS, NCRR NIH HHS.
Abstract (Originalsprache)
INTRODUCTION Although tau positron emission tomography (PET) imaging is effective for staging tau pathology, it is limited clinically by cost and availability. Machine learning models based on magnetic resonance imaging (MRI)– and amyloid PET–derived features may serve as useful screening tools for tau pathology. METHODS Multiple machine learning models were developed to classify tau positivity in the Braak III/IV region using structural MRI, amyloid PET, and demographic features. Alzheimer's Disease Neuroimaging Initiative (ADNI) ( n = 410) data were used for model training. Open Access Series of Imaging Studies (OASIS‐3; n = 143) and the Standardized Centralized Alzheimer's Disease Neuroimaging (SCAN; n = 154) data were used for external validation. RESULTS Logistic regression achieved the best performance with areas under the curve (AUCs) of 0.92 for both internal and external validation. Combined external validation yielded accuracy/sensitivity/specificity of 85%/83%/85%. Subjects with mild cognitive impairment and predicted tau positivity progressed to AD at a significantly faster pace ( p < 10 −6 ). DISCUSSION Our model demonstrates the feasibility of classifying tau burden in amyloid‐positive cohorts with MRI‐ and amyloid PET–derived features and may serve as a surrogate biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, School of Engineering, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Alzheimer's Disease Research Center, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department of Radiology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department of Neurology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
ORCID-Profile: Yun-Chi Lin, Yu-Hua Dean Fang
Förderung
- NIA NIH HHS
- NCATS NIH HHS
- NCRR NIH HHS
- NIDCD NIH HHS
- RRD VA
- NIH HHS
- NINDS NIH HHS
- NIBIB NIH HHS
Zitieren
APA
Lin, Y. C., Chiu, S. C., Massey, R., Fang, Y. D., & Alzheimer's Disease Neuroimaging Initiative (2026). Classification of tau status with machine learning models in amyloid‐positive cohorts. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71683
Vancouver
Lin YC, Chiu SC, Massey R, Fang YD, Alzheimer's Disease Neuroimaging Initiative. Classification of tau status with machine learning models in amyloid‐positive cohorts. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71683
BibTeX
@article{Lin2026,
author = {Lin, Yun-Chi and Chiu, Sheng-Chieh and Massey, Rebecca and Fang, Yu-Hua Dean and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
title = {Classification of tau status with machine learning models in amyloid‐positive cohorts},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71683}
}
EUVIMED